123 related articles for article (PubMed ID: 9068895)
1. Influence of sterilization processes on poly(epsilon-caprolactone) nanospheres.
Masson V; Maurin F; Fessi H; Devissaguet JP
Biomaterials; 1997 Feb; 18(4):327-35. PubMed ID: 9068895
[TBL] [Abstract][Full Text] [Related]
2. Production of Isotonic, Sterile, and Kinetically Stable Lipid-Core Nanocapsules for Injectable Administration.
Paese K; Ortiz M; Frank LA; Külkamp-Guerreiro IC; Rolim CM; Barros DM; Pohlmann AR; Guterres SS
AAPS PharmSciTech; 2017 Jan; 18(1):212-223. PubMed ID: 26956145
[TBL] [Abstract][Full Text] [Related]
3. Finalizing the properties of porous scaffolds of aliphatic polyesters through radiation sterilization.
Plikk P; Odelius K; Hakkarainen M; Albertsson AC
Biomaterials; 2006 Nov; 27(31):5335-47. PubMed ID: 16846641
[TBL] [Abstract][Full Text] [Related]
4. Phase transfer and characterization of poly(epsilon-caprolactone) and poly(L-lactide) microspheres.
Gadzinowski M; Slomkowski S; Elaïssari A; Pichot C
J Biomater Sci Polym Ed; 2000; 11(5):459-80. PubMed ID: 10896042
[TBL] [Abstract][Full Text] [Related]
5. Influence of excipients on characteristics and release profiles of poly(ε-caprolactone) microspheres containing immunoglobulin G.
Erdemli Ö; Keskin D; Tezcaner A
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():391-9. PubMed ID: 25579939
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.
Park EK; Lee SB; Lee YM
Biomaterials; 2005 Mar; 26(9):1053-61. PubMed ID: 15369694
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of Antioxidant Gallate Derivatives in Biocompatible Poly(ε-caprolactone)-b-Pluronic-b-Poly(ε-caprolactone) Micelles.
Fuentes I; Blanco-Fernandez B; Alvarado N; Leiva Á; Radić D; Alvarez-Lorenzo C; Concheiro A
Langmuir; 2016 Apr; 32(14):3331-9. PubMed ID: 26986801
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of poly(epsilon-caprolactone) polymer blends for the delivery of proteins.
Huatan H; Collett JH; Attwood D; Booth C
Biomaterials; 1995 Nov; 16(17):1297-303. PubMed ID: 8573667
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the thermo- and pH-responsive assembly of triblock copolymers based on poly(ethylene glycol) and functionalized poly(ε-caprolactone).
Safaei Nikouei N; Lavasanifar A
Acta Biomater; 2011 Oct; 7(10):3708-18. PubMed ID: 21672641
[TBL] [Abstract][Full Text] [Related]
10. Poly(epsilon-caprolactone) and poly(epsilon-caprolactone)-polyvinylpyrrolidone-iodine blends as ureteral biomaterials: characterisation of mechanical and surface properties, degradation and resistance to encrustation in vitro.
Jones DS; Djokic J; McCoy CP; Gorman SP
Biomaterials; 2002 Dec; 23(23):4449-58. PubMed ID: 12322963
[TBL] [Abstract][Full Text] [Related]
11. Poly-epsilon-caprolactone nanocapsules containing octyl methoxycinnamate: preparation and characterization.
Jiménez MM; Pelletier J; Bobin MF; Martini MC; Fessi H
Pharm Dev Technol; 2004 Aug; 9(3):329-39. PubMed ID: 15458238
[TBL] [Abstract][Full Text] [Related]
12. Investigation of polymer and nanoparticle properties with nicotinic acid and p-aminobenzoic acid grafted on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) via click chemistry.
Suksiriworapong J; Sripha K; Kreuter J; Junyaprasert VB
Bioconjug Chem; 2011 Apr; 22(4):582-94. PubMed ID: 21375231
[TBL] [Abstract][Full Text] [Related]
13. Biodegradability and biocompatibility of a pH- and thermo-sensitive hydrogel formed from a sulfonamide-modified poly(epsilon-caprolactone-co-lactide)-poly(ethylene glycol)-poly(epsilon-caprolactone-co-lactide) block copolymer.
Shim WS; Kim JH; Park H; Kim K; Chan Kwon I; Lee DS
Biomaterials; 2006 Oct; 27(30):5178-85. PubMed ID: 16797693
[TBL] [Abstract][Full Text] [Related]
14. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
15. Self-aggregation of cationically modified poly(ε-caprolactone)
Charoongchit P; Suksiriworapong J; Sripha K; Mao S; Sapin-Minet A; Maincent P; Junyaprasert VB
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():444-455. PubMed ID: 28024608
[TBL] [Abstract][Full Text] [Related]
16. Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice.
Kim SY; Lee YM; Baik DJ; Kang JS
Biomaterials; 2003 Jan; 24(1):55-63. PubMed ID: 12417178
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo degradation profile of aliphatic polyesters subjected to electron beam sterilization.
Dånmark S; Finne-Wistrand A; Schander K; Hakkarainen M; Arvidson K; Mustafa K; Albertsson AC
Acta Biomater; 2011 May; 7(5):2035-46. PubMed ID: 21316490
[TBL] [Abstract][Full Text] [Related]
18. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
19. Regulation of particle morphology of pH-dependent poly(epsilon-caprolactone)-poly(gamma-glutamic acid) micellar nanoparticles to combat breast cancer cells.
Chan AS; Chen CH; Huang CM; Hsieh MF
J Nanosci Nanotechnol; 2010 Oct; 10(10):6283-97. PubMed ID: 21137721
[TBL] [Abstract][Full Text] [Related]
20. Preparation of a bioactive and degradable poly(epsilon -caprolactone)/silica hybrid through a sol-gel method.
Rhee SH; Choi JY; Kim HM
Biomaterials; 2002 Dec; 23(24):4915-21. PubMed ID: 12361633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
